Phase 1 Study to Assess Safety and Efficacy of ANG003

Clinical trial NCT06052293 · COMPLETED

Trial details

NCT number: NCT06052293
Sponsor: Anagram Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency

Start date: 2023-08-25
Primary completion: 2024-07-08
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.